Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'non-small cell lung carcinoma' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Poncelet, AJ; Lonneux, M; Coche, E; Weynand, B; Noirhomme, P; Collard, P; Humblet, Y; Liistro, G; Pieters, T; Rodenstein, D; Scaillet, P
      PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    2. Jassem, J; Ramlau, R; Karnicka-Mlodkowska, H; Krawczyk, K; Krzakowski, M; Zatloukal, P; Lemarie, E; Hartmann, W; Novakova, L; O'Brien, M; Depierre, A
      A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients

      ANNALS OF ONCOLOGY
    3. Tormanen-Napankangas, U; Soini, Y; Paakko, P
      High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma

      APMIS
    4. Vansteenkiste, JF; Stroobants, SG
      The role of positron emission tomography with F-18-fluoro-2-deoxy-D-glucose in respiratory oncology

      EUROPEAN RESPIRATORY JOURNAL
    5. Chien, CR; Chen, SW; Hsieh, CY; Liang, JA; Yang, SN; Huang, CY; Lin, FJ
      Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    6. Yamamoto, AJ; Zhuang, HM; Alavi, A
      Detection of cranial metastases by F-18FDG positron emission tomography

      CLINICAL NUCLEAR MEDICINE
    7. Karnak, D; Ulubay, G; Kayacan, O; Beder, S; Ibis, E; Oflaz, G
      Evaluation of Cyfra 21-1: A potential tumor marker for non-small cell lungcarcinomas

      LUNG
    8. Gajra, A; Mehdi, SA; Kirshner, J; Newman, N; Graziano, SL
      Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma

      LUNG CANCER
    9. So, T; Takenoyama, M; Sugaya, A; Yasuda, M; Eifuku, R; Yoshimatsu, T; Osaki, T; Yasumoto, K
      Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2

      LUNG CANCER
    10. Vansteenkiste, JF; Bomans, P; Verbeken, EK; Nackaerts, KL; Demedts, MG
      Fatal pulmonary veno-occlusive disease possibly related to gemcitabine

      LUNG CANCER
    11. Castro, MAA; Schwartsmann, G; Moreira, JCF
      Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell lines

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    12. Bianco, V; Di Girolamo, B; Pignatelli, E; Speranza, I; Florio, G; Gemma, D; Girolami, M; Vietri, F; Marchei, P
      Gemcitabine as single agent therapy in advanced non small cell lung cancerand quality of life in the elderly

      PANMINERVA MEDICA
    13. Abrahams, JM; Torchia, M; Putt, M; Kaiser, LR; Judy, KD
      Risk factors affecting survival after brain metastases from non-small celllung carcinoma: a follow-up study of 70 patients

      JOURNAL OF NEUROSURGERY
    14. Hofmann, HS; Knolle, J; Bahn, H; Klapperstuck, T; Lautenschlager, C; Neef, H
      Flow cytometric analysis of DNA content and proliferation and immunohistochemical staining of Ki-67 in non-small cell lung cancer

      JOURNAL OF CARDIOVASCULAR SURGERY
    15. Tormanen-Napankangas, U; Soini, Y; Kahlos, K; Kinnula, V; Paakko, P
      Expression of caspases-3,-6 and-8 and their relation to apoptosis in non-small cell lung carcinoma

      INTERNATIONAL JOURNAL OF CANCER
    16. Yamada, M; Shiroko, T; Kawaguchi, Y; Sugiyama, Y; Egilmez, NK; Chen, FA; Bankert, RB
      CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors

      INTERNATIONAL JOURNAL OF CANCER
    17. Bardet, E; Moro-Sibilot, D; Le Chevalier, T; Massard, G; Douillard, JY; Theobald, S; Astoul, P; Baldeyrou, P; Bazelly, B; Brechot, J; Breton, JL; Grivaux, M; Jacoulet, P; Khalil, A; Lemarie, E; Martinet, Y; Milleron, B; Paesmans, M; Pujol, JL; Quoix, AE; Ranfaing, E; Riviere, A; Sancho-Garnier, H; Souquet, PJ; Spaeth, D; Stoebner-Delbarre, A; Thiberville, L; Touboul, E; Vaylet, F; Vergnon, JM; Westeel, V; Depierre, A; Lagrange, JL
      Standards, Options and Recommendations for the management of locally advanced non small cell lung carcinoma

      BULLETIN DU CANCER
    18. Lee, HZ
      Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell

      BRITISH JOURNAL OF PHARMACOLOGY
    19. Mountain, CF
      The international system for staging lung cancer

      SEMINARS IN SURGICAL ONCOLOGY
    20. Rosell, R; Felip, E
      Role of multimodality treatment for lung cancer

      SEMINARS IN SURGICAL ONCOLOGY
    21. Komaki, R; Putnam, JB; Walsh, G; Lee, JS; Cox, JD
      The management of superior sulcus tumors

      SEMINARS IN SURGICAL ONCOLOGY
    22. Alpard, SK; Duarte, AG; Bidani, A; Zwischenberger, JB
      Pathogenesis and management of respiratory insufficiency following pulmonary resection

      SEMINARS IN SURGICAL ONCOLOGY
    23. Mendes-da-Silva, P; Moreira, A; Duro-da-Costa, J; Matias, D; Monteiro, C
      Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    24. Papatheofanis, FJ
      Utility evaluations for Markov states of lung cancer for PET-based diseasemanagement

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    25. Varela, G; Novoa, N; Jimenez, MF
      Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    26. Nguyen, BD; Roarke, MC
      Demonstration of non-small-cell lung carcinoma by indium-111 octreotide scintigraphy

      CLINICAL NUCLEAR MEDICINE
    27. Langendijk, JA; Ten Velde, GPM; Aaronson, NK; De Jong, JMA; Muller, MJ; Wouters, EFM
      Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    28. Ortegel, JW; Staren, ED; Faber, LP; Warren, WH; Braun, DP
      Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    29. Bretcha-Boix, P; Rami-Porta, R; Mateu-Navarro, M; Hoyuela-Alonso, C; Marco-Molina, C
      Surgical treatment of lung cancer with adrenal metastasis

      LUNG CANCER
    30. Langendijk, H; Thunnissen, E; Arends, JW; de Jong, S; ten Velde, G; Lamers, R; Guinee, D; Holden, J; Wouters, M
      Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy

      RADIOTHERAPY AND ONCOLOGY
    31. Langendijk, H; Aaronson, NK; de Jong, JMA; ten Velde, GPM; Muller, MJ; Wouters, M
      The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy

      RADIOTHERAPY AND ONCOLOGY
    32. Watine, J
      Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    33. Chizhikov, VV; Zborovskaya, IB; Tatosyan, AG; Gasparyan, AV
      Gene p73: Deletions and expression in non-small-cell lung carcinoma cells

      MOLECULAR BIOLOGY
    34. Kamiyoshihara, M; Kawashima, O; Sakata, S; Hirai, T; Ishikawa, S; Morishita, Y
      Management of ipsilateral intrapulmonary metastases in the new TNM system for non-small cell lung cancer

      JOURNAL OF CARDIOVASCULAR SURGERY
    35. Kamiyoshihara, M; Kawashima, O; Ishikawa, S; Morishita, Y
      Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer

      JOURNAL OF CARDIOVASCULAR SURGERY
    36. van Rens, MTM; Zanen, P; de la Riviere, AB; Elbers, HRJ; van Swieten, HA; van den Bosch, JMM
      Survival in synchronous vs single lung cancer - Upstaging better reflects prognosis

      CHEST
    37. Kosuda, S; Ichihara, K; Watanabe, M; Kobayashi, H; Kusano, S
      Decision-tree sensitivity analysis for cost-effectiveness of chest 2-Fluoro-2-D-[F-18]Fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan

      CHEST
    38. van Rens, MTM; de la Riviere, AB; Elbers, HRJ; van den Bosch, JMM
      Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA

      CHEST
    39. Brechot, JM
      Carboplatine place in the treatment of lung cancer

      BULLETIN DU CANCER
    40. Heniford, BT; Arca, MJ; Walsh, RM; Gill, IS
      Laparoscopic adrenalectomy for cancer

      SEMINARS IN SURGICAL ONCOLOGY
    41. Campanella, N; Moraca, A; Pergolini, M; Daher, W; Fianchini, A; Sabbatini, A; Brunelli, A; Al-Refai, M
      Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

      MEDICAL ONCOLOGY
    42. Xinarianos, G; Scott, FM; Liloglou, T; Prime, W; Callaghan, J; Gosney, JR; Field, JK
      Telomerase activity in non-small cell lung carcinomas correlates with smoking status

      INTERNATIONAL JOURNAL OF ONCOLOGY
    43. Puglisi, F; Barbone, F; Damante, G; Bruckbauer, M; Di Lauro, V; Beltrami, CA; Di Loreto, C
      Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma

      MODERN PATHOLOGY
    44. Hosomi, Y; Ohe, Y; Mito, K; Uramoto, H; Moriyama, E; Tanaka, K; Kodama, K; Niho, S; Goto, K; Ohmatsu, H; Matsumoto, T; Hojo, F; Kakinuma, R; Nishiwaka, Y
      Phase I study of cisplatin and docetaxel plus mitomycin C in patients withmetastatic non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    45. Castro, MA; Schwartsmann, G; Bernard, EA; Moreira, JCF
      Phenotype modulation of cellular UV-sensitivity

      CANCER LETTERS
    46. Ozkara, HA; Ozkara, S; Topcu, S; Criss, WE
      Amplification of the c-myc oncogene in non-small cell lung cancer

      TUMORI
    47. Meert, AP; Berghmans, T; Branle, F; Lemaitre, F; Mascaux, C; Rubesova, E; Vermylen, P; Paesmans, M; Sculier, JP
      Phase II and III studies with new drugs for non-small cell lung cancer: A systematic review of the literature with a methodology quality assessment

      ANTICANCER RESEARCH
    48. Tinnemans, MMFJ; Lenders, MHJH; Ten Velde, GPM; Blijham, GH; Ramaekers, FCS; Schutte, B
      Prognostic value of cytokinetic parameters in lung cancer after in vivo bromodeoxyuridine labelling

      ANTICANCER RESEARCH
    49. Lu, YJ; Dong, XY; Shipley, J; Zhang, RG; Cheng, SJ
      Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma

      LUNG CANCER
    50. Magnani, P; Carretta, A; Rizzo, G; Fazio, F; Vanzulli, A; Lucignani, G; Zannini, P; Messa, C; Landoni, C; Gilardi, MC; Del Maschio, A
      FDG/PET and spiral CT image fusion for medistinal lymph node assessment ofnon-small cell lung cancer patients

      JOURNAL OF CARDIOVASCULAR SURGERY
    51. Setterfield, J; Shirlaw, PJ; Lazarova, Z; Bryant, BM; Bhogal, BS; Harman, K; Challacombe, SJ; Black, MM
      Paraneoplastic cicatricial pemphigoid

      BRITISH JOURNAL OF DERMATOLOGY
    52. ATHANASSIADOU P; DOSIOS T; PETRAKAKOU E; LIOSSI A; ZERVA C; ATHANASSIADES P
      P53 AND BCL-2 PROTEIN EXPRESSION IN NON-SMALL-CELL LUNG-CARCINOMA

      Diagnostic cytopathology
    53. Mangili, E; Cigala, C; Arrigoni, G; Rovere, E; Gattuso, C; Santambrogio, G; Garancini, P
      Cell loss and proliferation in non-small cell lung carcinoma: correlation with histological subtype

      EUROPEAN JOURNAL OF HISTOCHEMISTRY
    54. VANSTEENKISTE JF; DELEYN PR; DENEFFE GJ; LIEVENS YN; NACKAERTS KL; VANRAEMDONCK DE; VANDERSCHUEREN E; LERUT TE; DEMEDTS MG
      VINDESINE-IFOSFAMIDE-PLATINUM (VIP) INDUCTION CHEMOTHERAPY IN SURGICALLY STAGED IIIA-N2 NON-SMALL-CELL LUNG-CANCER - A PROSPECTIVE-STUDY

      Annals of oncology
    55. Vansteenkiste, JF; Stroobants, SG; De Leyn, PR; Dupont, PJ; Verbeken, EK
      Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N-2 non-small-cell lung cancer: A prospective pilot study

      ANNALS OF ONCOLOGY
    56. Vansteenkiste, JF; Stroobants, SG; Dupont, PJ; De Leyn, PR; De Wever, WF; Verbeken, EK; Nuyts, JL; Maes, FP; Bogaert, JG
      FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    57. Langendijk, JA; Tjwa, MKT; de Jong, JMA; ten Velde, GPM; Wouters, EFM
      Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?

      RADIOTHERAPY AND ONCOLOGY
    58. Krepela, E; Prochazka, J; Karova, B; Cermak, J; Roubkova, H
      Cysteine proteases and cysteine protease inhibitors in non-small cell lungcancer

      NEOPLASMA
    59. Wong, MP; Cheung, KN; Yuen, ST; Fu, KH; Chan, ASY; Leung, SY; Chung, LP
      Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung

      JOURNAL OF PATHOLOGY
    60. Quoix, E; Moreau, L; Oster, JP
      Drugs and radiopotentiation in locally advanced non-small cell lung cancer

      TREATMENT OPTIMIZATION FOR LUNG CANCER
    61. TOMIROTTI M; GALASSI B; DAMBROSIO M; FOSSATI V; GRAMEGNA G; COLOMBO F; ROVEJ R; SCANNI A
      CIS CARBOPLATIN PLUS VINORELBINE +/- RADIOTHERAPY IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA/

      Journal of chemotherapy
    62. DALQUEN P; MOCH H; FEICHTER G; LEHMANN M; SOLER M; STULZ P; JORDAN P; TORHORST J; MIHATSCH MJ; SAUTER G
      DNA ANEUPLOIDY, S-PHASE FRACTION, NUCLEAR P53 POSITIVITY, AND SURVIVAL IN NON-SMALL-CELL LUNG-CARCINOMA

      Virchows Archiv
    63. BOSCH S; SIAVOSHIAN S; JACQUOT C; TOMASONI C; DABOUIS G; ELANBALOUSSI Y; LENEEL T; MORE M; ROUSSAKIS C
      CORRELATION BETWEEN MULTIDRUG-RESISTANCE AND THE DEGREE OF DIFFERENTIATION OF NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA (NSCLC) IN-VITRO AND IN-VIVO

      Anticancer research
    64. VUILLEZ JP; MORO D; BRICHON PY; ROUVIER E; BRAMBILLA E; BARBET J; PELTIER P; MEYER P; SARRAZIN R; BRAMBILLA C
      2-STEP IMMUNOSCINTIGRAPHY FOR NON-SMALL-CELL LUNG-CANCER STAGING USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER/

      The Journal of nuclear medicine
    65. MAINWARING PN; NICOLSON MC; HICKISH T; PENSON R; JOEL S; SLEVIN M; SMITH IE
      CONTINUOUS INFUSIONAL TOPOTECAN IN ADVANCED BREAST AND NON-SMALL-CELLLUNG-CANCER - NO EVIDENCE OF INCREASED EFFICACY

      British Journal of Cancer
    66. LILOGLOU T; ROSS H; PRIME W; DONNELLY RJ; SPANDIDOS DA; GOSNEY JR; FIELD JK
      P53 GENE ABERRATIONS IN NON-SMALL-CELL LUNG CARCINOMAS FROM A SMOKINGPOPULATION

      British Journal of Cancer
    67. GRESS FG; SAVIDES TJ; SANDLER A; KESLER K; CONCES D; CUMMINGS O; MATHUR P; IKENBERRY S; BILDERBACK S; HAWES R
      ENDOSCOPIC ULTRASONOGRAPHY, FINE-NEEDLE ASPIRATION BIOPSY GUIDED BY ENDOSCOPIC ULTRASONOGRAPHY, AND COMPUTED-TOMOGRAPHY IN THE PREOPERATIVESTAGING OF NON-SMALL-CELL LUNG-CANCER - A COMPARISON STUDY

      Annals of internal medicine
    68. SRINIVASAN R; MAXWELL SA
      A CELLULAR PROTEIN ACTIVATES THE SEQUENCE-SPECIFIC DNA-BINDING OF P53BY INTERACTING WITH THE CENTRAL CONSERVED REGION

      Oncogene
    69. STAALVANDENBREKEL AJ; THUNNISSEN FBJM; BUURMAN WA; WOUTERS EFM
      EXPRESSION OF E-SELECTIN, INTERCELLULAR-ADHESION MOLECULE (ICAM)-1 AND VASCULAR CELL-ADHESION MOLECULE (VCAM)-1 IN NON-SMALL-CELL LUNG-CARCINOMA

      Virchows Archiv
    70. DAVIDSON A; MOODY TW; GOZES I
      REGULATION OF VIP GENE-EXPRESSION IN GENERAL - HUMAN LUNG-CANCER CELLS IN PARTICULAR

      Journal of molecular neuroscience
    71. BRUNDAGE MD; MACKILLOP WJ
      LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER - DO WE KNOW THE QUESTIONS - A SURVEY OF RANDOMIZED TRIALS FROM 1966-1993

      Journal of clinical epidemiology
    72. LISCIA E; RIOU D; SIAVOSHIAN S; BOESCH S; LEBERT V; TOMASONI C; DABOUIS G; BIARD JF; ROUSSAKIS C
      TERMINAL DIFFERENTIATION IN A NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA CORRELATES WITH INCREASED EXPRESSION OF P53

      Anticancer research
    73. VOLM M; KOOMAGI R; MATTERN J
      INTERRELATIONSHIPS BETWEEN MICROVESSEL DENSITY, EXPRESSION OF VEGF AND RESISTANCE TO DOXORUBICIN OF NON-SMALL LUNG-CELL CARCINOMA

      Anticancer research
    74. KWA HB; MICHALIDES RJAM; DIJKMAN JH; MOOI WJ
      THE PROGNOSTIC VALUE OF NCAM, P53 AND CYCLIN D1 IN RESECTED NON-SMALL-CELL LUNG-CANCER

      Lung cancer
    75. GAMBHIR SS; HOH CK; PHELPS ME; MADAR I; MADDAHI J
      DECISION TREE SENSITIVITY ANALYSIS FOR COST-EFFECTIVENESS OF FDG-PET IN THE STAGING AND MANAGEMENT OF NON-SMALL-CELL LUNG-CARCINOMA

      The Journal of nuclear medicine
    76. DALQUEN P; SAUTER G; TORHORST J; SCHULTHEISS E; JORDAN P; LEHMANN S; SOLER M; STULZ P; MIHATSCH MJ; GUDAT F
      NUCLEAR P53 OVEREXPRESSION IS AN INDEPENDENT PROGNOSTIC PARAMETER IN NODE-NEGATIVE NON-SMALL-CELL LUNG-CARCINOMA

      Journal of pathology
    77. BETTICHER DC; HEIGHWAY J; HASLETON PS; ALTERMATT HJ; RYDER WDJ; CERNY T; THATCHER N
      PROGNOSTIC-SIGNIFICANCE OF CCND1 (CYCLIN D1) OVEREXPRESSION IN PRIMARY RESECTED NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    78. PRITCHARD RS; ANTHONY SP
      CHEMOTHERAPY PLUS RADIOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED, UNRESECTABLE, NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS

      Annals of internal medicine
    79. TIAN Y; GEBITEKIN C; MARTIN P; SATUR CMR; MEARNS A; WALKER DR
      INFLUENCE OF HEPARIN THROMBOPROPHYLAXIS ON PLASMA LEUKOCYTE ELASTASE LEVELS FOLLOWING LOBECTOMY FOR LUNG-CARCINOMA

      Blood coagulation & fibrinolysis
    80. META M; PONTE M; GUASTELLA M; SEMINO C; PIETRA G; RATTO GB; MELIOLI G
      DETECTION OF OLIGOCLONAL T-LYMPHOCYTES IN LYMPH-NODES DRAINING FROM ADVANCED NON-SMALL-CELL LUNG-CANCER

      Cancer immunology and immunotherapy
    81. WONG MP; CHUNG LP; YUEN ST; LEUNG SY; CHAN SY; WANG E; FU KH
      IN-SITU DETECTION OF EPSTEIN-BARR-VIRUS IN NON-SMALL-CELL LUNG CARCINOMAS

      Journal of pathology
    82. CASTELLO G; LERZA R; MENCOBONI M; CAVALLINI D; FLEGO G; CERRUTI A; BALLARINO P; BOGLIOLO G; PANNACCIULLI I
      CISPLATIN, 5-FLUOROURACIL AND ALPHA-INTERFERON IN NON-SMALL-CELL LUNG-CARCINOMA - A TOXICITY STUDY

      Anticancer research
    83. SARANDAKOU A; POULAKIS N; RIZOS D; TRAKAKIS E; PHOCAS I
      SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) AND NEURON SPECIFIC ENOLASE (NSE) IN SMALL-CELL LUNG-CARCINOMA

      Anticancer research
    84. RIOU D; ROUSSAKIS C; ROBILLARD N; BIARD JF; VERBIST JF
      BISTRAMIDE-A-INDUCED IRREVERSIBLE ARREST OF CELL-PROLIFERATION IN A NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA IS SIMILAR TO INDUCTION OF TERMINAL MATURATION

      Biology of the cell
    85. THEUNISSEN PHMH; LEERS MPG; BOLLEN ECM
      PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN FORMALIN-FIXED TISSUE OF NON-SMALL-CELL LUNG-CARCINOMA

      Histopathology
    86. LIEWALD F; SUNDERPLASSMANN L; VALET G; WULF G; WEISS M; SCHILDBERG FW
      FLOW-CYTOMETRY OF NON-SMALL-CELL BRONCHOGENIC-CARCINOMA AND ITS PROGNOSTIC-SIGNIFICANCE

      Chirurg


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 12:27:04